Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAkin, Semiha
dc.contributor.authorCan, Gulbeyaz
dc.contributor.authorAydiner, Adnan
dc.contributor.authorOzdilli, Kursat
dc.contributor.authorDurna, Zehra
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T16:04:21Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T16:04:21Z
dc.date.issued2010
dc.identifier.issn1462-3889
dc.identifier.urihttps://dx.doi.org/10.1016/j.ejon.2010.01.003
dc.identifier.urihttp://hdl.handle.net/11446/3286
dc.descriptionWOS: 000284746700008en_US
dc.descriptionPubMed ID: 20149733en_US
dc.description.abstractThe diagnosis of lung cancer in the advanced stage of Illness the poor prognosis associated with the disease and the side effects of chemotherapy all have an impact on various dimensions of quality of life (QoL) The purpose of the research The current study was designed to describe the QoL and symptom distress of lung cancer patients undergoing chemotherapy and to explore the relationships between demographic/treatment-related characteristics and QoL Methods and sample The sample consisted of 154 lung cancer patients undergoing chemotherapy The symptom experiences and QoL of lung cancer patients undergoing chemotherapy were evaluated using the Memorial Symptom Assessment Scale and Quality of Life Index - Cancer Version Results The lung cancer patients had low QoL scores The scores on the Health and Functioning subscale were the lowest (20 33 +/- 5 59) while those of the Family subscale were the highest (27 66 +/- 2 77) The most common physical symptoms experienced by lung cancer patients were lack of energy coughing pain lack of appetite and nausea while the psychological symptoms were feeling nervous difficulty sleeping feeling sad and worrying There was a negative relationship between the symptom distress and quality of life scores (r = -045 p < 0 000) Females and those with low income levels and performance status experienced greater symptom distress Conclusions Lung cancer patients receiving chemotherapy suffer many limitations due to the symptoms and disruptions to their QoL, arising from both the disease process and its treatment Lung cancer patients need to be assessed regularly and supported (c) 2010 Elsevier Ltd All rights reserveden_US
dc.language.isoengen_US
dc.publisherELSEVIER SCI LTDen_US
dc.identifier.doi10.1016/j.ejon.2010.01.003en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLung canceren_US
dc.subjectQuality of lifeen_US
dc.subjectSymptomsen_US
dc.subjectChemotherapyen_US
dc.titleQuality of life, symptom experience and distress of lung cancer patients undergoing chemotherapyen_US
dc.typearticleen_US
dc.relation.journalEUROPEAN JOURNAL OF ONCOLOGY NURSINGen_US
dc.departmentDBÜen_US
dc.identifier.issue5en_US
dc.identifier.volume14en_US
dc.identifier.startpage400en_US
dc.identifier.endpage409en_US
dc.contributor.authorID0000-0002-5368-0893en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Akin, Semiha -- Durna, Zehra] Istanbul Bilim Univ, Florence Nightingale Hastanesi, Hemsirelik Yuksekokulu, TR-34349 Istanbul, Turkey -- [Can, Gulbeyaz] Istanbul Univ, Florence Nightingale Sch Nursing, Istanbul, Turkey -- [Aydiner, Adnan] Istanbul Univ, Inst Oncol, Istanbul, Turkey -- [Ozdilli, Kursat] Halic Univ, Inst Hlth Sci, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster